Latest It Compliance News

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.

Netwealth Group Limited reported a strong December quarter with record custodial inflows of $8.4 billion and total funds under administration reaching $125.6 billion, while announcing a $101 million compensation charge related to the First Guardian collapse.

High-Tech Metals has raised $10.7 million through the exercise of nearly 43 million options, bolstering its push towards gold production at the Dam-Damsel project and expanding exploration across its vast Western Australian tenure.

Australian Dairy Nutritionals reported a 152% surge in nutritional powder sales despite regulatory hurdles in Vietnam, while expanding its Future brand footprint across China.

Chilwa Minerals has finalised the last tranche of its $8 million private placement, bolstered by insider participation, and is advancing plans for a Nasdaq dual listing in the first half of 2026.

The Australian Competition and Consumer Commission has advanced its review of Ampol’s acquisition of EG Australia to a more detailed Phase 2 assessment, signalling potential competition concerns. Ampol remains optimistic about completing the deal by mid-2026 despite the regulatory scrutiny.

Galileo Mining Ltd has responded to an ASX price and volume query, confirming no undisclosed material information exists to explain recent trading activity. The company attributes the surge to positive market sentiment around its Norseman Project and lithium joint venture with Mineral Resources.

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Emerald Resources has announced a 27% increase in the Mineral Resource Estimate for its Memot Gold Project in Cambodia, now totaling 1.7 million ounces of gold, with full permitting in place to begin development this year.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Eagle Mountain Mining has launched a Placement Options Offer for 61.3 million options attaching to recent placement shares, potentially raising $1.23 million upon exercise. The offer supports ongoing exploration and strategic initiatives in Arizona copper projects.